TREM‐1: intracellular signaling pathways and interaction with pattern recognition receptors

TREM‐1 is an important signaling receptor expressed on neutrophils and monocytes that plays an important role in systemic infections. Here, we review the intracellular signaling pathways that mediate the immunological effects of TREM‐1. Because of the absence of signaling motifs, TREM‐1 constitutively associates with DAP12 for induction of intracellular signals. After phosphorylation of DAP12, production of chemokines and cytokines is induced. Moreover, TREM‐1 also modulates signaling pathways induced by known classes of PRRs, such as TLRs and NLRs. The exact mechanisms through which TREM‐1 influences TLR and NLR pathways are still largely elusive.

[1]  S. Biswas,et al.  Role of MMPs in orchestrating inflammatory response in human monocytes via a TREM‐1‐PI3K‐NF‐κB pathway , 2012, Journal of leukocyte biology.

[2]  Hiroaki Ito,et al.  TREM‐2, triggering receptor expressed on myeloid cell‐2, negatively regulates TLR responses in dendritic cells , 2012, European journal of immunology.

[3]  S. Orfanos,et al.  TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen , 2011, BMC infectious diseases.

[4]  Y. Jung,et al.  Expression of a soluble triggering receptor expressed on myeloid cells‐1 (sTREM‐1) correlates with clinical disease activity in intestinal Behcet's disease , 2011, Inflammatory bowel diseases.

[5]  Eun Soo Kim,et al.  Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. , 2011, Life sciences.

[6]  A. Cerwenka,et al.  Btk is a positive regulator in the TREM-1/DAP12 signaling pathway. , 2011, Blood.

[7]  S. Kida,et al.  Transcriptional regulation of mouse TREM-1 gene in RAW264.7 macrophage-like cells. , 2011, Life sciences.

[8]  E. Elinav,et al.  Regulation of the antimicrobial response by NLR proteins. , 2011, Immunity.

[9]  L. Hazlett,et al.  TREM-1 Amplifies Corneal Inflammation after Pseudomonas aeruginosa Infection by Modulating Toll-Like Receptor Signaling and Th1/Th2-Type Immune Responses , 2011, Infection and Immunity.

[10]  L. Joosten,et al.  TREM-1 interaction with the LPS/TLR4 receptor complex. , 2011, European cytokine network.

[11]  F. Novelli,et al.  Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. , 2011, Blood.

[12]  S. Kunkel,et al.  Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) Modulates Immune Responses to Aspergillus fumigatus During Fungal Asthma in Mice , 2011, Immunological investigations.

[13]  J. Christman,et al.  Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. , 2010, Experimental cell research.

[14]  L. Liaudet,et al.  Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice , 2010, Critical care.

[15]  H. Redmond,et al.  ST2 Negatively Regulates TLR2 Signaling, but Is Not Required for Bacterial Lipoprotein-Induced Tolerance , 2010, The Journal of Immunology.

[16]  Tomohiro Watanabe,et al.  NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. , 2010, The Journal of clinical investigation.

[17]  M. Fujimoto,et al.  Elevated Serum Concentrations of Triggering Receptor Expressed on Myeloid Cells-1 in Diffuse Cutaneous Systemic Sclerosis: Association with Severity of Pulmonary Fibrosis , 2010, The Journal of Rheumatology.

[18]  L. Hazlett,et al.  β-Defensins 2 and 3 Together Promote Resistance to Pseudomonas aeruginosa Keratitis1 , 2009, The Journal of Immunology.

[19]  Katharina,et al.  TREM-1 Activation Alters the Dynamics of Pulmonary IRAK-M Expression In Vivo and Improves Host Defense during Pneumococcal Pneumonia1 , 2009, The Journal of Immunology.

[20]  H. Schild,et al.  Signaling Pathways of the TREM-1- and TLR4-Mediated Neutrophil Oxidative Burst , 2009, Journal of Innate Immunity.

[21]  H. Hara,et al.  CARD9 versus CARMA1 in innate and adaptive immunity. , 2009, Trends in immunology.

[22]  L. Hazlett,et al.  Beta-Defensin 2 Promotes Resistance Against Infection With P. aeruginosa , 2009 .

[23]  D. McVicar,et al.  TREM and TREM-like receptors in inflammation and disease. , 2009, Current opinion in immunology.

[24]  L. Hazlett,et al.  β-Defensin-2 Promotes Resistance against Infection with P. aeruginosa1 , 2009, The Journal of Immunology.

[25]  O. Sharif,et al.  From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. , 2008, Immunobiology.

[26]  Lewis L Lanier,et al.  Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.

[27]  K. Nagashima,et al.  Murine β‐defensin 2 promotes TLR‐4/MyD88‐mediated and NF‐κB‐dependent atypical death of APCs via activation of TNFR2 , 2008, Journal of leukocyte biology.

[28]  A. Cerwenka,et al.  The TREM-1/DAP12 pathway. , 2008, Immunology letters.

[29]  R. Baron,et al.  'Tuning' of type I interferon–induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages , 2008, Nature Immunology.

[30]  M. Colonna,et al.  Uncovering the TREM-1-TLR connection. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[31]  M. Ornatowska,et al.  Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[32]  H. Schild,et al.  TREM-1 ligand expression on platelets enhances neutrophil activation. , 2007, Blood.

[33]  M. Ornatowska,et al.  TREM‐1 expression in macrophages is regulated at transcriptional level by NF‐κB and PU.1 , 2007, European journal of immunology.

[34]  S. Dreskin,et al.  Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. , 2007, Immunology letters.

[35]  J. Penninger,et al.  The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors , 2007, Nature Immunology.

[36]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[37]  L. Piccio,et al.  Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis , 2007, European journal of immunology.

[38]  Adelheid Cerwenka,et al.  Non-T Cell Activation Linker (NTAL) Negatively Regulates TREM-1/DAP12-Induced Inflammatory Cytokine Production in Myeloid Cells1 , 2007, The Journal of Immunology.

[39]  D. Underhill,et al.  The many faces of ITAMs. , 2007, Trends in immunology.

[40]  H. Kohsaka,et al.  Lipopolysaccharide-Induced Up-Regulation of Triggering Receptor Expressed on Myeloid Cells-1 Expression on Macrophages Is Regulated by Endogenous Prostaglandin E21 , 2007, The Journal of Immunology.

[41]  M. Netea,et al.  Triggering receptor expressed on myeloid cells‐1 (TREM‐1) amplifies the signals induced by the NACHT‐LRR (NLR) pattern recognition receptors , 2006, Journal of leukocyte biology.

[42]  M. Colonna,et al.  The TREM receptor family and signal integration , 2006, Nature Immunology.

[43]  O. Lesur,et al.  Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. , 2006, International immunology.

[44]  L. Piccio,et al.  Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.

[45]  L. Lanier,et al.  Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP121 , 2006, The Journal of Immunology.

[46]  J. Ruland,et al.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity , 2006, Nature.

[47]  L. Hazlett,et al.  SIGIRR Promotes Resistance against Pseudomonas aeruginosa Keratitis by Down-Regulating Type-1 Immunity and IL-1R1 and TLR4 Signaling1 , 2006, The Journal of Immunology.

[48]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[49]  Xiaoxia Li,et al.  SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different Mechanisms* , 2005, Journal of Biological Chemistry.

[50]  Yunbi Lu,et al.  Production of matrix metalloproteinase‐9 by activated human monocytes involves a phosphatidylinositol‐3 kinase/Akt/IKKα/NF‐κB pathway , 2005, Journal of leukocyte biology.

[51]  M. Béné,et al.  Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock , 2005, Intensive Care Medicine.

[52]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[53]  F. Liew,et al.  A novel negative regulator for IL-1 receptor and Toll-like receptor 4. , 2005, Immunology letters.

[54]  T. van der Poll,et al.  Cutting Edge: Expression Patterns of Surface and Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Human Endotoxemia1 , 2004, The Journal of Immunology.

[55]  I. Wilson,et al.  Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 A. , 2004, Journal of molecular biology.

[56]  M. Béné,et al.  A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis , 2004, The Journal of experimental medicine.

[57]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[58]  H. Rammensee,et al.  Triggering Receptor Expressed on Myeloid Cells-1 in Neutrophil Inflammatory Responses: Differential Regulation of Activation and Survival , 2004, The Journal of Immunology.

[59]  F. Liew,et al.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.

[60]  I. Azuma,et al.  Mycobacterium bovis BCG Cell Wall-Specific Differentially Expressed Genes Identified by Differential Display and cDNA Subtraction in Human Macrophages , 2004, Infection and Immunity.

[61]  D. Tenen,et al.  Phosphorylation of C/EBPα Inhibits Granulopoiesis , 2004, Molecular and Cellular Biology.

[62]  Shiang-Jong Tzeng,et al.  Location is everything: lipid rafts and immune cell signaling. , 2003, Annual review of immunology.

[63]  G. Stark,et al.  SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.

[64]  M. Colonna,et al.  TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. , 2003, The Journal of infectious diseases.

[65]  M. Colonna.  TREMs in the immune system and beyond , 2003, Nature Reviews Immunology.

[66]  C. Buonsanti,et al.  A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response1 , 2003, The Journal of Immunology.

[67]  Naděžda Brdičková,et al.  Non–T Cell Activation Linker (NTAL) , 2002, The Journal of experimental medicine.

[68]  John Calvin Reed,et al.  Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. , 2002, Biochemical and biophysical research communications.

[69]  L. Kwak,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.

[70]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[71]  C. Janeway,et al.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.

[72]  Sankar Ghosh,et al.  Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.

[73]  M. Colonna,et al.  A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001, The Journal of experimental medicine.

[74]  C. Nathan,et al.  TREM-1: A new regulator of innate immunity in sepsis syndrome , 2001, Nature Medicine.

[75]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[76]  M. Colonna,et al.  Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.

[77]  O. Inanami,et al.  Roles of p38 MAPK, PKC and PI3‐K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes , 2000, FEBS letters.

[78]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[79]  L. Wahl,et al.  Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs. , 1987, Cellular Immunology.

[80]  Tomohiro Watanabe,et al.  Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.

[81]  K. Wüthrich,et al.  Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A. , 2004, Journal of molecular biology.